DR. REDDYS LABORATORIES LTD.
NSE : DRREDDYBSE : 500124ISIN
CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse
: Dr. Reddy's
BSE4604.70-29.65 (-0.64 % )
PREV CLOSE (Rs.) 4634.35
OPEN PRICE (Rs.) 4645.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 73635
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE4600.95 -33.9 (-0.73 % )
PREV CLOSE(Rs.) 4634.85
OPEN PRICE (Rs.) 4655.05
BID PRICE (QTY) 4600.95 (364 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1012014
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Financial ratio
| Particulars | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 121.90 | 117.47 | 57.04 | 77.93 | 124.89 |
| CEPS(Rs) | 188.51 | 183.19 | 119.86 | 137.74 | 178.58 |
| DPS(Rs) | 25.00 | 20.00 | 20.00 | 20.00 | 20.00 |
| Book NAV/Share(Rs) | 932.31 | 840.01 | 752.35 | 734.72 | 731.49 |
| Tax Rate(%) | -7.67 | 16.83 | 32.43 | 19.08 | 26.27 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 14.10 | 20.57 | 16.46 | 17.41 | 23.03 |
| EBIT Margin(%) | 11.01 | 15.41 | 10.01 | 11.39 | 18.89 |
| Pre Tax Margin(%) | 10.44 | 14.84 | 9.46 | 10.94 | 18.36 |
| PAT Margin (%) | 11.25 | 12.34 | 6.39 | 8.86 | 13.54 |
| Cash Profit Margin (%) | 17.89 | 19.69 | 13.93 | 16.09 | 19.57 |
| Performance Ratios | |||||
| ROA(%) | 8.95 | 8.66 | 4.23 | 6.14 | 11.05 |
| ROE(%) | 13.38 | 14.42 | 7.40 | 10.20 | 18.95 |
| ROCE(%) | 10.81 | 13.41 | 8.21 | 9.77 | 19.55 |
| Asset Turnover(x) | 0.80 | 0.70 | 0.66 | 0.69 | 0.82 |
| Sales/Fixed Asset(x) | 0.94 | 0.87 | 0.86 | 0.92 | 1.13 |
| Working Capital/Sales(x) | 3.25 | 2.96 | 3.96 | 11.23 | 2.86 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.07 | 1.15 | 1.17 | 1.09 | 0.89 |
| Receivable days | 93.92 | 94.98 | 100.33 | 101.86 | 96.43 |
| Inventory Days | 71.52 | 74.03 | 73.63 | 69.56 | 60.11 |
| Payable days | 39.56 | 39.46 | 37.10 | 31.00 | 28.67 |
| Valuation Parameters | |||||
| PER(x) | 25.57 | 23.62 | 36.51 | 33.78 | 24.30 |
| PCE(x) | 16.54 | 15.14 | 17.37 | 19.11 | 16.99 |
| Price/Book(x) | 3.34 | 3.30 | 2.77 | 3.58 | 4.15 |
| Yield(%) | 0.80 | 0.72 | 0.96 | 0.76 | 0.66 |
| EV/Net Sales(x) | 3.07 | 3.22 | 2.76 | 3.39 | 3.51 |
| EV/Core EBITDA(x) | 17.41 | 14.13 | 15.71 | 18.22 | 14.08 |
| EV/EBIT(x) | 27.91 | 20.86 | 27.55 | 29.79 | 18.57 |
| EV/CE(x) | 2.45 | 2.25 | 1.79 | 2.28 | 2.76 |
| M Cap / Sales | 2.96 | 2.98 | 2.42 | 3.07 | 3.33 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 13.39 | 8.17 | 0.60 | -8.81 | 3.63 |
| Core EBITDA Growth(%) | -12.08 | 40.27 | -5.19 | -31.87 | 2.99 |
| EBIT Growth(%) | -19.03 | 66.59 | -11.62 | -45.02 | -2.21 |
| PAT Growth(%) | 3.34 | 108.92 | -27.43 | -40.35 | -9.79 |
| EPS Growth(%) | 3.77 | 105.96 | -26.81 | -37.60 | -8.92 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.14 | 0.28 | 0.41 | 0.40 | 0.27 |
| Current Ratio(x) | 1.75 | 1.88 | 1.52 | 1.15 | 1.86 |
| Quick Ratio(x) | 1.26 | 1.31 | 1.10 | 0.81 | 1.46 |
| Interest Cover(x) | 19.61 | 26.78 | 18.14 | 25.51 | 35.61 |
| Total Debt/Mcap(x) | 0.04 | 0.08 | 0.15 | 0.11 | 0.06 |
